Exploring the Updated Roles of Ferroptosis in Liver Diseases: Mechanisms, Regulators, and Therapeutic Implications
Cell Biochemistry and Biophysics · 2024
DOI: 10.1007/s12013-024-01611-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Ting Ge und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nantong University, Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Ferroptosis, Liver Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 182 Literaturangaben. Gefördert von: Postgraduate Research & Practice Innovation Program of Jiangsu Province, Natural Science Research Project of Jiangsu Higher Education Institutions, Large Instruments Open Foundation of Nantong University.
Abstract (Originalsprache)
Ferroptosis, a newly discovered mode of cell death, is a type of iron-dependent regulated cell death characterized by intracellular excessive lipid peroxidation and imbalanced redox. As the liver is susceptible to oxidative damage and the abnormal iron accumulation is a major feature of most liver diseases, studies on ferroptosis in the field of liver diseases are of great interest. Studies show that targeting the key regulators of ferroptosis can effectively alleviate or even reverse the deterioration process of liver diseases. System Xc- and glutathione peroxidase 4 are the main defense regulators of ferroptosis, while acyl-CoA synthetase long chain family member 4 is a key enzyme causing peroxidation in ferroptosis. Generally speaking, ferroptosis should be suppressed in alcoholic liver disease, non-alcoholic fatty liver disease, and drug-induced liver injury, while it should be induced in liver fibrosis and hepatocellular carcinoma. In this review, we summarize the main regulators involved in ferroptosis and then the mechanisms of ferroptosis in different liver diseases. Treatment options of drugs targeting ferroptosis are further concluded. Determining different triggers of ferroptosis can clarify the mechanism of ferroptosis occurs at both physiological and pathological levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Nantong University, Nantong, Jiangsu, China.
- School of Pharmacy, Nantong University, Nantong, Jiangsu, China. ntdxlcf@ntu.edu.cn.
Förderung
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- Natural Science Research Project of Jiangsu Higher Education Institutions
- Large Instruments Open Foundation of Nantong University
- The Sixth 226 High Level Talent Training Project of Nantong City
- Innovation and Entrepreneurship Training Program for Undergraduates of Nantong University
Zitieren
APA
Ge, T., Wang, Y., Han, Y., Bao, X., & Lu, C. (2024). Exploring the Updated Roles of Ferroptosis in Liver Diseases: Mechanisms, Regulators, and Therapeutic Implications. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01611-3
Vancouver
Ge T, Wang Y, Han Y, Bao X, Lu C. Exploring the Updated Roles of Ferroptosis in Liver Diseases: Mechanisms, Regulators, and Therapeutic Implications. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01611-3
BibTeX
@article{Ge2024,
author = {Ge, Ting and Wang, Yang and Han, Yiwen and Bao, Xiaofeng and Lu, Chunfeng},
title = {Exploring the Updated Roles of Ferroptosis in Liver Diseases: Mechanisms, Regulators, and Therapeutic Implications},
journal = {Cell Biochemistry and Biophysics},
year = {2024},
doi = {10.1007/s12013-024-01611-3}
}
EUVIMED